Annual Cash & Cash Equivalents
$13.59 M
+$3.12 M+29.81%
December 31, 2023
Summary
- As of February 8, 2025, MGRM annual cash & cash equivalents is $13.59 million, with the most recent change of +$3.12 million (+29.81%) on December 31, 2023.
- During the last 3 years, MGRM annual cash & cash equivalents has risen by +$8.00 million (+143.24%).
- MGRM annual cash & cash equivalents is now at all-time high.
Performance
MGRM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.57 M
+$9.26 M+126.73%
September 30, 2024
Summary
- As of February 8, 2025, MGRM quarterly cash and cash equivalents is $16.57 million, with the most recent change of +$9.26 million (+126.73%) on September 30, 2024.
- Over the past year, MGRM quarterly cash and cash equivalents has increased by +$2.98 million (+21.90%).
- MGRM quarterly cash and cash equivalents is now -3.12% below its all-time high of $17.10 million, reached on June 30, 2023.
Performance
MGRM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MGRM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.8% | +21.9% |
| 3 y3 years | +143.2% | +58.2% |
| 5 y5 years | +1373.7% | +58.2% |
MGRM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.5% | -3.1% | +199.2% |
| 5 y | 5-year | at high | +485.9% | -3.1% | +614.2% |
| alltime | all time | at high | +5660.5% | -3.1% | +614.2% |
Monogram Orthopaedics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.57 M(+126.7%) |
| Jun 2024 | - | $7.31 M(-27.5%) |
| Mar 2024 | - | $10.08 M(-25.8%) |
| Dec 2023 | $13.59 M(+29.8%) | $13.59 M(-8.6%) |
| Sep 2023 | - | $14.88 M(-13.0%) |
| Jun 2023 | - | $17.10 M(+121.5%) |
| Mar 2023 | - | $7.72 M(-26.3%) |
| Dec 2022 | $10.47 M | $10.47 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $10.29 M(+85.9%) |
| Dec 2021 | $5.54 M(-0.9%) | - |
| Dec 2021 | - | $5.54 M(-0.9%) |
| Dec 2020 | $5.59 M(+140.9%) | $5.59 M(-40.7%) |
| Jun 2020 | - | $9.42 M(+306.0%) |
| Dec 2019 | $2.32 M(+151.5%) | $2.32 M |
| Dec 2018 | $922.10 K(+290.9%) | - |
| Dec 2017 | $235.90 K | - |
FAQ
- What is Monogram Orthopaedics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Monogram Orthopaedics?
- What is Monogram Orthopaedics annual cash & cash equivalents year-on-year change?
- What is Monogram Orthopaedics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Monogram Orthopaedics?
- What is Monogram Orthopaedics quarterly cash and cash equivalents year-on-year change?
What is Monogram Orthopaedics annual cash & cash equivalents?
The current annual cash & cash equivalents of MGRM is $13.59 M
What is the all time high annual cash & cash equivalents for Monogram Orthopaedics?
Monogram Orthopaedics all-time high annual cash & cash equivalents is $13.59 M
What is Monogram Orthopaedics annual cash & cash equivalents year-on-year change?
Over the past year, MGRM annual cash & cash equivalents has changed by +$3.12 M (+29.81%)
What is Monogram Orthopaedics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MGRM is $16.57 M
What is the all time high quarterly cash and cash equivalents for Monogram Orthopaedics?
Monogram Orthopaedics all-time high quarterly cash and cash equivalents is $17.10 M
What is Monogram Orthopaedics quarterly cash and cash equivalents year-on-year change?
Over the past year, MGRM quarterly cash and cash equivalents has changed by +$2.98 M (+21.90%)